9:22 AM
Leo Group India
| ||
| Israel's Teva Pharmaceutical Industries to foray into India through JV with Proctor ... Economic Times AHMEDABAD: Global pharma giant, Teva Pharmaceutical Industries (TPI) shall foray into India through a joint venture with US based Proctor & Gamble (P&G) and will set up its first manufacturing facility at Sanand in Gujarat, a top state official said here. See all stories on this topic » | ||
| ||
| Government may ease FDI norms in pharmaceutical industry Economic Times NEW DELHI: The government is likely to take a less harsh stand on foreign direct investment (FDI) in pharmaceutical companies to ensure a balance between public health concerns and the need to attract investments. An inter-ministerial group set up by the ... See all stories on this topic » | ||
| Biocon close to oral insulin deal with Bristol-Myers Squibb Economic Times Four months after its partnership with Pfizer fell through, Biocon is now close to inking a deal with US-based biopharmaceuticals giant Bristol-Myers Squibb (BMS), to partner for the development and commercialization of its oral insulin product IN-105, which is ... See all stories on this topic » | ||
| BioMarin Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ ... MarketWatch (press release) NOVATO, Calif., Jul 25, 2012 (GlobeNewswire via COMTEX) -- BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) today announced that on July 16, 2012, the compensation committee of BioMarin's board of directors approved the grant to two employees of ... See all stories on this topic » | ||
| TEXT-Fitch:Global pharmaceutical approvals moderate as patent cliff peaks Reuters July 25 - Fitch Ratings expects the Food and Drug Administration (FDA) will approve fewer novel drugs in 2012 as compared to 2011 while the industry faces several ongoing operational risks, according to a new report. Fitch believes that the total of 30 new ... See all stories on this topic » | ||
| Salix Pharmaceuticals Announces 2Q2012 Financial Results Conference Call ... MarketWatch (press release) RALEIGH, N.C., Jul 25, 2012 (BUSINESS WIRE) -- Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will report second quarter 2012 financial results following the close of the U.S. financial markets on Wednesday, August 8, ... See all stories on this topic » | ||
| Antitrust: Commission enforcement action in pharmaceutical sector following ... eGov monitor Following its competition inquiry into the pharmaceutical sector of 2008/2009 (see IP/09/1098 and MEMO/09/321) the European Commission has issued a statement of objections against Lundbeck and other pharmaceutical companies in a major investigation ... See all stories on this topic » | ||
| Acura Pharmaceuticals to Host Second Quarter 2012 Financial Results ... MarketWatch (press release) PALATINE, IL, Jul 25, 2012 (MARKETWIRE via COMTEX) -- Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) , a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that the company plans to report financial results for the ... See all stories on this topic » |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment